Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/20/10 → 2/4/13 |
Funding
- Altor BioScience Corporation (CA-ALT-801-02-09//2R44CA097550-05A1)
- National Cancer Institute (CA-ALT-801-02-09//2R44CA097550-05A1)
PROT# CA-ALT-801-02-09: Phase Ib/II Study of ALT-801 with Cisplatin in Patients with Metastatic Melanoma
- Kuzel, Timothy Michael (PD/PI)
Project: Research project